Evaluation of ctDNA-based <i>ESR1</i> testing in breast cancer: results from the first external quality assessment scheme in China
The variability in genotyping accuracy and reporting standards underscores the importance of EQA and educational guidance to ensure the provision of high-quality clinical services.
Authors
- Guigao Lin (ORCID: https://orcid.org/0000-0002-0406-9078)
- Jing Li (ORCID: https://orcid.org/0000-0002-2052-9302)
- Kuo Zhang (ORCID: https://orcid.org/0000-0002-7996-6996)
Institutions
- Academy of Medical Sciences (GB)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Hospital (CN)
Publication Details
- Journal
- Expert Review of Molecular Diagnostics
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1080/14737159.2025.2498542
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China